| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
POU class 5 homeobox 1 | 0.441 | 0.846 | 0.95 |
|
disease | 0.320 | None | 1.000 | 2 | 0 | 2005 | 2018 | ||||||||
|
Nanog homeobox | 0.531 | 0.654 | 0.72 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 2005 | 2008 | ||||||||
|
KIT ligand | 0.473 | 0.885 | 0.85 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 2009 | 2018 | ||||||||
|
tumor protein p53 | 0.236 | 0.962 | 0.53 |
|
disease | 0.040 | None | 0.750 | 4 | 0 | 1993 | 2014 | ||||||||
|
fibroblast growth factor 4 | 0.588 | 0.577 | 0.14 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 1990 | 1998 | ||||||||
|
estrogen receptor 1 | 0.324 | 0.962 | 1.00 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 1995 | 2003 | ||||||||
|
immunoglobulin heavy variable 1-12 (pseudogene) | 0.569 | 0.654 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 1990 | 2006 | |||||||||
|
bleomycin hydrolase | 0.716 | 0.423 | 0.13 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2005 | 2005 | ||||||||
|
microRNA 511 | 0.647 | 0.538 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2015 | 2015 | |||||||||
|
POU class 5 homeobox 1 pseudogene 3 | 0.452 | 0.808 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2011 | 2011 | |||||||||
|
POU class 5 homeobox 1 pseudogene 4 | 0.452 | 0.808 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2011 | 2011 | |||||||||
|
solute carrier family 22 member 3 | 0.531 | 0.846 | 7.8E-10 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2011 | 2011 | ||||||||
|
SRY-box transcription factor 2 | 0.405 | 0.808 | 0.71 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2014 | 2014 | ||||||||
|
thymine DNA glycosylase | 0.674 | 0.385 | 5.6E-04 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2013 | 2013 | ||||||||
|
teratocarcinoma-derived growth factor 1 | 0.584 | 0.731 | 9.2E-11 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2016 | 2016 | ||||||||
|
teratocarcinoma-derived growth factor 1 pseudogene 3 | 0.631 | 0.500 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2016 | 2016 | |||||||||
|
XPA, DNA damage recognition and repair factor | 0.520 | 0.846 | 7.9E-05 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2000 | 2000 | ||||||||
|
DNA methyltransferase 1 | 0.406 | 0.885 | 1.00 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
programmed cell death 1 | 0.402 | 0.846 | 0.42 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
dual specificity phosphatase 1 | 0.491 | 0.808 | 1.0E-02 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2016 | 2016 | ||||||||
|
epidermal growth factor receptor | 0.295 | 0.885 | 0.37 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2002 | 2002 | ||||||||
|
preferentially expressed antigen in melanoma | 0.531 | 0.577 | 2.4E-07 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2016 | 2016 | ||||||||
|
CD274 molecule | 0.324 | 0.923 | 1.9E-02 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
isocitrate dehydrogenase (NADP(+)) 1 | 0.424 | 0.808 | 2.6E-12 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2013 | 2013 | ||||||||
|
isocitrate dehydrogenase (NADP(+)) 2 | 0.434 | 0.808 | 0.88 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2013 | 2013 |